europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future

01/06/2021
NEWS RELEASE
Brussels, 27 May 2021

Last week EuropaBio organised EFIB 2021 kick-off webinar ‘How to accelerate biotech innovation for a sustainable future”. The event was co-hosted by DSM and Planet B.io, both located at the Biotech Campus Delft.

Agnes Borg, Industrial Biotechnology Director at EuropaBio, welcomed participants to the webinar, noting that industrial biotechnology is well placed to contribute to the objectives of the EU Green Deal.

Dr Claire Skentelbery, Director-General of EuropaBio, looks forward to welcoming participants to EFIB 2021 in Vienna, Austria with local host LISAvienna. Austria has a strong industrial biotechnology landscape so is the ideal backdrop for a return to an in-person conference. A key theme of EFIB2021 is how industrial biotechnology delivers across a range of sectors through innovative products & processes, while contributing towards EU Green Deal objectives. In particular, innovation will be showcased through the Start-up Village and Innovation Campus, for which applications are open until 16 June.

Cindy Gerhardt, Managing Director, Planet-B.io at the Biotech Campus Delft

Cindy introduced Planet-B.io as the open innovation ecosystem for industrial biotechnology. She discussed the benefits of collaboration between corporates and start-ups, from providing investment opportunities and increasing entrepreneurship for corporates to access capital, increased structure and credibility for start-ups. She shared Planet-B.io learnings on corporate-startup interactions in the DSM ecosystem, noting that financial, technical, and business support is crucial for start-ups. Joining a triple-helix, multi-tenant campus like the Biotech Campus Delft and becoming part of an innovation ecosystem can be a key step in accessing this support. Cindy also shared her positive experiences with the recent DSM meat replacement innovation challenge and discussed the valuable role that those competitions can provide to all parties. However, she advised that start-ups should thoroughly decide whether or not to take part in those challenges and that it would generally offer the best fit for founders if the requested scope is rather targeted to a specific topic, than only a broad call for innovation.

Amadeus Driando Ahnan-Winarno – Co-Founder & Head of Technology, Better Nature

Amadeus briefly introduced Better Nature, who won the EFIB2020 Start-Up Forum. Better Nature is a UK-based start-up that offers meat alternative food products using tempeh fermentation. With this approach, the company provides a plant-based alternative to other meat-free products which use artificial or ultra-processed ingredients. In the near future, the pipeline will also include the Better Nature burger and dairy ingredients. The focus of his talk was on what startups need in moving from lab to market, summarizing that confidentiality, customizability, scaleability, and product-market fit are among the major points to be addressed by founders, and that every product development stage has different needs. From his experience, up-scaling manufacturing processes is among one of the most challenging steps. Amadeus also provided insights on the most recent and successful crowdfunding campaign of his company.

Rob van der Meij (Partner, Capricorn Partners)

Rob’s opinion is that industrial biotech is the next stage of investment. In his presentation, he gave an overview of Capricorn Partner’s portfolio of which a majority is related to industrial biotechnology. With regard to the market Rob perceives industrial biotechnology as a sustainable alternatives to existing approaches in chemistry and other industrial sectors. Cost reductions in working with DNA and new platform technologies have contributed to more applications, he said. Rob added that biotech innovation in this field is not going for the lowest prices and also pointed to the fact that cars in their early days were not cheaper than horses. From his perspective, the drivers for industrial biotechnology are much stronger today than ten years ago. He particularly mentioned aspects related to consumer demand and policy and regulation such as the EU Green Deal. In addition, he emphasized that founders should not be shy with regard to defending their developments towards corporates and investors.

EFIB 2021 will take place 6-7 October 2021 in Vienna, Austria as an onsite event. More information, the programme and registration here.

EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023


Read more
23/05/2023

EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation


Read more
10/05/2023

#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee


Read more
10/05/2023

Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski


Read more

Important links

  • SwedenBIO joins EuropaBio: helping innovative companies succeed!
  • Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies